Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Vessel Prosthesis Implantation | 29 | 2024 | 1426 | 1.960 |
Why?
|
Stents | 35 | 2024 | 3162 | 1.860 |
Why?
|
Endovascular Procedures | 30 | 2024 | 2139 | 1.740 |
Why?
|
Endarterectomy, Carotid | 12 | 2024 | 549 | 1.730 |
Why?
|
Angioplasty | 15 | 2020 | 354 | 1.720 |
Why?
|
Vascular Surgical Procedures | 23 | 2023 | 1470 | 1.650 |
Why?
|
Aortic Aneurysm, Abdominal | 24 | 2020 | 1214 | 1.530 |
Why?
|
Femoral Artery | 11 | 2021 | 824 | 1.480 |
Why?
|
Carotid Stenosis | 10 | 2024 | 853 | 1.390 |
Why?
|
Lower Extremity | 18 | 2020 | 1188 | 1.320 |
Why?
|
Ischemia | 17 | 2022 | 1863 | 1.250 |
Why?
|
Peripheral Arterial Disease | 20 | 2022 | 1246 | 1.230 |
Why?
|
Blood Vessel Prosthesis | 13 | 2021 | 953 | 1.100 |
Why?
|
Mesenteric Vascular Occlusion | 5 | 2019 | 91 | 0.980 |
Why?
|
Catheterization, Peripheral | 3 | 2021 | 340 | 0.850 |
Why?
|
Mesenteric Artery, Superior | 3 | 2016 | 95 | 0.830 |
Why?
|
Angioplasty, Balloon | 9 | 2018 | 588 | 0.620 |
Why?
|
Celiac Artery | 2 | 2016 | 65 | 0.560 |
Why?
|
Carotid Artery Diseases | 6 | 2018 | 872 | 0.550 |
Why?
|
Aortic Aneurysm | 1 | 2021 | 648 | 0.540 |
Why?
|
Chi-Square Distribution | 28 | 2022 | 3425 | 0.540 |
Why?
|
Vascular Grafting | 5 | 2018 | 152 | 0.510 |
Why?
|
Intermittent Claudication | 5 | 2016 | 303 | 0.490 |
Why?
|
Limb Salvage | 14 | 2022 | 464 | 0.440 |
Why?
|
Ischemic Attack, Transient | 2 | 2018 | 878 | 0.440 |
Why?
|
Time Factors | 52 | 2024 | 39872 | 0.430 |
Why?
|
Peripheral Vascular Diseases | 3 | 2012 | 488 | 0.430 |
Why?
|
Aortic Rupture | 6 | 2019 | 315 | 0.430 |
Why?
|
Embolism | 2 | 2020 | 401 | 0.410 |
Why?
|
Watchful Waiting | 1 | 2016 | 509 | 0.400 |
Why?
|
Treatment Outcome | 63 | 2024 | 64378 | 0.380 |
Why?
|
Balloon Occlusion | 3 | 2020 | 125 | 0.380 |
Why?
|
Aortography | 4 | 2018 | 420 | 0.370 |
Why?
|
Wound Healing | 9 | 2021 | 2783 | 0.370 |
Why?
|
Popliteal Artery | 3 | 2018 | 309 | 0.370 |
Why?
|
Postoperative Complications | 16 | 2024 | 15637 | 0.360 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2024 | 2747 | 0.340 |
Why?
|
Groin | 2 | 2021 | 106 | 0.340 |
Why?
|
Hospital Mortality | 10 | 2020 | 5272 | 0.340 |
Why?
|
Aorta, Thoracic | 3 | 2019 | 1094 | 0.340 |
Why?
|
Aortic Aneurysm, Thoracic | 4 | 2024 | 695 | 0.330 |
Why?
|
Intestines | 2 | 2010 | 1906 | 0.330 |
Why?
|
Risk Factors | 56 | 2024 | 73809 | 0.310 |
Why?
|
Stroke | 11 | 2022 | 9694 | 0.310 |
Why?
|
Endoleak | 2 | 2020 | 110 | 0.300 |
Why?
|
Imaging, Three-Dimensional | 4 | 2018 | 4048 | 0.290 |
Why?
|
Aged | 75 | 2024 | 168218 | 0.280 |
Why?
|
Retrospective Studies | 55 | 2024 | 80168 | 0.270 |
Why?
|
Endarterectomy | 5 | 2021 | 195 | 0.270 |
Why?
|
Quality Indicators, Health Care | 5 | 2016 | 1797 | 0.260 |
Why?
|
Aged, 80 and over | 40 | 2024 | 58683 | 0.260 |
Why?
|
Foot | 1 | 2010 | 573 | 0.260 |
Why?
|
Risk Assessment | 32 | 2024 | 23884 | 0.260 |
Why?
|
Saphenous Vein | 2 | 2020 | 517 | 0.260 |
Why?
|
Diabetic Foot | 1 | 2010 | 380 | 0.260 |
Why?
|
Anticoagulants | 2 | 2019 | 4777 | 0.240 |
Why?
|
Blood Loss, Surgical | 3 | 2017 | 653 | 0.240 |
Why?
|
Wound Infection | 2 | 2017 | 243 | 0.230 |
Why?
|
Veins | 4 | 2018 | 765 | 0.230 |
Why?
|
Magnetic Resonance Angiography | 4 | 2016 | 1431 | 0.230 |
Why?
|
Radiography, Interventional | 3 | 2018 | 1112 | 0.220 |
Why?
|
Carotid Artery Injuries | 1 | 2004 | 96 | 0.220 |
Why?
|
Patient Selection | 12 | 2019 | 4244 | 0.220 |
Why?
|
Multivariate Analysis | 19 | 2017 | 12096 | 0.220 |
Why?
|
Embolization, Therapeutic | 6 | 2020 | 1407 | 0.220 |
Why?
|
Arterial Occlusive Diseases | 4 | 2012 | 747 | 0.210 |
Why?
|
Ultrasonography, Interventional | 3 | 2019 | 1489 | 0.210 |
Why?
|
Renal Artery Obstruction | 3 | 2013 | 219 | 0.210 |
Why?
|
Iliac Aneurysm | 1 | 2002 | 37 | 0.210 |
Why?
|
Ribs | 1 | 2024 | 252 | 0.210 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2024 | 97 | 0.210 |
Why?
|
Decision Support Techniques | 3 | 2017 | 1996 | 0.210 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2009 | 1214 | 0.200 |
Why?
|
Prosthesis-Related Infections | 3 | 2021 | 486 | 0.200 |
Why?
|
Carotid Artery, Internal | 1 | 2024 | 435 | 0.190 |
Why?
|
Logistic Models | 19 | 2017 | 13276 | 0.190 |
Why?
|
Male | 74 | 2024 | 358747 | 0.190 |
Why?
|
Boston | 11 | 2017 | 9304 | 0.180 |
Why?
|
Asymptomatic Diseases | 3 | 2019 | 584 | 0.180 |
Why?
|
Odds Ratio | 15 | 2017 | 9650 | 0.180 |
Why?
|
Predictive Value of Tests | 10 | 2020 | 15225 | 0.180 |
Why?
|
Blood Transfusion | 2 | 2017 | 1321 | 0.180 |
Why?
|
Aorta, Abdominal | 2 | 2019 | 625 | 0.170 |
Why?
|
Thrombosis | 4 | 2019 | 2929 | 0.170 |
Why?
|
Middle Aged | 50 | 2024 | 219568 | 0.170 |
Why?
|
Female | 73 | 2024 | 390323 | 0.170 |
Why?
|
Carotid-Cavernous Sinus Fistula | 2 | 2013 | 37 | 0.170 |
Why?
|
Prosthesis Design | 5 | 2021 | 2105 | 0.170 |
Why?
|
Neck | 1 | 2004 | 731 | 0.170 |
Why?
|
Databases, Factual | 12 | 2020 | 7980 | 0.160 |
Why?
|
Surgical Wound Infection | 5 | 2021 | 1526 | 0.160 |
Why?
|
Decompression, Surgical | 1 | 2024 | 604 | 0.160 |
Why?
|
Polyethylene Terephthalates | 1 | 1999 | 115 | 0.160 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2021 | 153 | 0.160 |
Why?
|
Humans | 90 | 2024 | 758406 | 0.160 |
Why?
|
Length of Stay | 10 | 2018 | 6439 | 0.160 |
Why?
|
Multilevel Analysis | 1 | 2018 | 150 | 0.150 |
Why?
|
Device Removal | 3 | 2020 | 633 | 0.150 |
Why?
|
Coated Materials, Biocompatible | 2 | 2005 | 312 | 0.150 |
Why?
|
Hirudins | 1 | 1999 | 179 | 0.150 |
Why?
|
Leg | 2 | 2013 | 1087 | 0.150 |
Why?
|
After-Hours Care | 1 | 2018 | 102 | 0.150 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2017 | 100 | 0.140 |
Why?
|
Kaplan-Meier Estimate | 9 | 2017 | 6493 | 0.140 |
Why?
|
Arteriosclerosis | 5 | 2005 | 1055 | 0.140 |
Why?
|
Antithrombins | 1 | 1999 | 294 | 0.130 |
Why?
|
Reoperation | 9 | 2020 | 4282 | 0.130 |
Why?
|
Vascular Patency | 5 | 2018 | 895 | 0.130 |
Why?
|
Thromboembolism | 1 | 2022 | 996 | 0.130 |
Why?
|
Renal Artery | 2 | 2010 | 351 | 0.130 |
Why?
|
Aneurysm, Ruptured | 2 | 2012 | 459 | 0.130 |
Why?
|
Retroperitoneal Space | 1 | 2016 | 171 | 0.130 |
Why?
|
Eligibility Determination | 1 | 2019 | 419 | 0.120 |
Why?
|
Proportional Hazards Models | 11 | 2017 | 12440 | 0.120 |
Why?
|
Angiography | 1 | 2020 | 1599 | 0.120 |
Why?
|
Recurrence | 10 | 2020 | 8426 | 0.120 |
Why?
|
Quality Improvement | 3 | 2016 | 3806 | 0.120 |
Why?
|
Peritoneum | 1 | 2016 | 224 | 0.120 |
Why?
|
Health Status Disparities | 3 | 2024 | 1831 | 0.120 |
Why?
|
Silver Compounds | 1 | 2014 | 23 | 0.120 |
Why?
|
Carotid Artery, Common | 3 | 2023 | 175 | 0.120 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 411 | 0.110 |
Why?
|
Databases as Topic | 6 | 2011 | 472 | 0.110 |
Why?
|
Education, Medical, Graduate | 2 | 2018 | 2359 | 0.110 |
Why?
|
Postoperative Hemorrhage | 1 | 2017 | 413 | 0.110 |
Why?
|
Alginates | 1 | 2014 | 248 | 0.110 |
Why?
|
Aortic Diseases | 1 | 2019 | 735 | 0.110 |
Why?
|
Iliac Artery | 2 | 2006 | 342 | 0.110 |
Why?
|
Bandages | 1 | 2014 | 269 | 0.100 |
Why?
|
United States | 24 | 2022 | 72136 | 0.100 |
Why?
|
Polyesters | 1 | 2014 | 371 | 0.100 |
Why?
|
Jugular Veins | 1 | 2013 | 210 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 6 | 2012 | 20500 | 0.100 |
Why?
|
Radiation Dosage | 2 | 2018 | 1956 | 0.100 |
Why?
|
Graft Occlusion, Vascular | 1 | 2015 | 537 | 0.100 |
Why?
|
Ticlopidine | 1 | 2017 | 731 | 0.100 |
Why?
|
Anti-Infective Agents, Local | 1 | 2014 | 247 | 0.100 |
Why?
|
Polyethylenes | 1 | 2014 | 290 | 0.100 |
Why?
|
Heparin | 1 | 2019 | 1632 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2017 | 4839 | 0.100 |
Why?
|
Occupational Health | 1 | 2017 | 805 | 0.090 |
Why?
|
Propensity Score | 1 | 2018 | 1907 | 0.090 |
Why?
|
Diabetes Mellitus | 3 | 2018 | 5816 | 0.090 |
Why?
|
Glomerular Filtration Rate | 2 | 2016 | 2154 | 0.090 |
Why?
|
Ultrasonography | 2 | 2016 | 5952 | 0.090 |
Why?
|
Ultrasonography, Doppler, Duplex | 2 | 2016 | 198 | 0.090 |
Why?
|
Chronic Disease | 7 | 2020 | 9267 | 0.080 |
Why?
|
Acute Disease | 3 | 2024 | 7225 | 0.080 |
Why?
|
New England | 3 | 2021 | 1053 | 0.080 |
Why?
|
Retreatment | 3 | 2016 | 596 | 0.080 |
Why?
|
Viscera | 1 | 2010 | 138 | 0.080 |
Why?
|
Patients | 1 | 2016 | 904 | 0.080 |
Why?
|
Ankle Brachial Index | 1 | 2010 | 159 | 0.080 |
Why?
|
Hypoglycemic Agents | 2 | 2018 | 3069 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2013 | 892 | 0.070 |
Why?
|
Patient Discharge | 4 | 2013 | 3433 | 0.070 |
Why?
|
Treatment Failure | 3 | 2019 | 2640 | 0.070 |
Why?
|
Quality of Life | 3 | 2019 | 13285 | 0.070 |
Why?
|
Sex Factors | 6 | 2024 | 10504 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2013 | 3364 | 0.070 |
Why?
|
Hospitals | 2 | 2022 | 3887 | 0.070 |
Why?
|
Occupational Exposure | 1 | 2017 | 1809 | 0.070 |
Why?
|
Insulin | 2 | 2018 | 6578 | 0.070 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2002 | 1486 | 0.070 |
Why?
|
Registries | 4 | 2017 | 8175 | 0.070 |
Why?
|
Patient Admission | 1 | 2013 | 1372 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2307 | 0.060 |
Why?
|
Thinness | 1 | 2009 | 490 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2016 | 2083 | 0.060 |
Why?
|
Punctures | 2 | 2019 | 365 | 0.060 |
Why?
|
Internship and Residency | 2 | 2018 | 5865 | 0.060 |
Why?
|
Body Mass Index | 3 | 2017 | 12876 | 0.060 |
Why?
|
Incidence | 6 | 2016 | 21272 | 0.060 |
Why?
|
Subclavian Vein | 1 | 2024 | 58 | 0.060 |
Why?
|
Mesentery | 1 | 2005 | 202 | 0.060 |
Why?
|
Hypertension, Renovascular | 1 | 2005 | 116 | 0.060 |
Why?
|
Patient Readmission | 2 | 2021 | 3261 | 0.060 |
Why?
|
Laparotomy | 1 | 2007 | 465 | 0.060 |
Why?
|
Blood Glucose | 1 | 2018 | 6346 | 0.060 |
Why?
|
Foreign-Body Migration | 1 | 2006 | 218 | 0.060 |
Why?
|
Fluoroscopy | 2 | 2018 | 944 | 0.060 |
Why?
|
Physical Examination | 1 | 2010 | 1245 | 0.060 |
Why?
|
Staphylococcal Infections | 1 | 2013 | 1406 | 0.060 |
Why?
|
Fellowships and Scholarships | 1 | 2012 | 1115 | 0.050 |
Why?
|
Hemorrhage | 3 | 2022 | 3400 | 0.050 |
Why?
|
Embolectomy | 2 | 2017 | 129 | 0.050 |
Why?
|
Health Care Costs | 2 | 2017 | 3245 | 0.050 |
Why?
|
Disease Progression | 2 | 2016 | 13468 | 0.050 |
Why?
|
Critical Illness | 4 | 2017 | 2703 | 0.050 |
Why?
|
Tomography, Spiral Computed | 1 | 2003 | 273 | 0.050 |
Why?
|
Preoperative Care | 2 | 2017 | 2249 | 0.050 |
Why?
|
Gold | 1 | 2005 | 479 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 3992 | 0.050 |
Why?
|
Clavicle | 1 | 2023 | 224 | 0.050 |
Why?
|
Survival Rate | 4 | 2013 | 12721 | 0.050 |
Why?
|
Kidney | 1 | 2016 | 7016 | 0.050 |
Why?
|
Prosthesis Failure | 1 | 2006 | 1198 | 0.050 |
Why?
|
Radiography | 3 | 2012 | 6954 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20055 | 0.040 |
Why?
|
Ape Diseases | 1 | 1999 | 3 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2019 | 6520 | 0.040 |
Why?
|
Age Factors | 5 | 2016 | 18358 | 0.040 |
Why?
|
Tunica Intima | 1 | 2001 | 459 | 0.040 |
Why?
|
Creatinine | 2 | 2016 | 1892 | 0.040 |
Why?
|
Overweight | 1 | 2010 | 2411 | 0.040 |
Why?
|
Cysteine Endopeptidases | 1 | 2001 | 548 | 0.040 |
Why?
|
Osteotomy | 1 | 2024 | 836 | 0.040 |
Why?
|
Embolic Protection Devices | 1 | 2019 | 41 | 0.040 |
Why?
|
Inpatients | 1 | 2010 | 2551 | 0.040 |
Why?
|
Factor Xa | 1 | 2019 | 167 | 0.040 |
Why?
|
Hyperplasia | 1 | 2001 | 1154 | 0.040 |
Why?
|
Carotid Arteries | 1 | 2022 | 939 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2019 | 512 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4217 | 0.040 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2005 | 1730 | 0.040 |
Why?
|
Multienzyme Complexes | 1 | 2001 | 665 | 0.040 |
Why?
|
Comorbidity | 4 | 2013 | 10495 | 0.040 |
Why?
|
Laparoscopy | 1 | 2010 | 2147 | 0.040 |
Why?
|
Cell Adhesion | 2 | 2002 | 3090 | 0.040 |
Why?
|
Cost of Illness | 2 | 2019 | 1936 | 0.040 |
Why?
|
Upper Extremity | 1 | 2022 | 661 | 0.040 |
Why?
|
Adult | 8 | 2024 | 219935 | 0.040 |
Why?
|
Radiation Monitoring | 1 | 2017 | 103 | 0.030 |
Why?
|
Cell Division | 2 | 2002 | 4458 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1999 | 1628 | 0.030 |
Why?
|
Learning Curve | 1 | 2018 | 231 | 0.030 |
Why?
|
Follow-Up Studies | 5 | 2013 | 39059 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2001 | 1150 | 0.030 |
Why?
|
Hematocrit | 1 | 2017 | 627 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6821 | 0.030 |
Why?
|
Diabetic Angiopathies | 1 | 2001 | 802 | 0.030 |
Why?
|
Perioperative Period | 1 | 2017 | 262 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2024 | 2060 | 0.030 |
Why?
|
Emergency Medical Services | 1 | 2007 | 1915 | 0.030 |
Why?
|
Cell Movement | 3 | 2002 | 5201 | 0.030 |
Why?
|
Hexuronic Acids | 1 | 2014 | 145 | 0.030 |
Why?
|
Glucuronic Acid | 1 | 2014 | 150 | 0.030 |
Why?
|
Dogs | 1 | 1999 | 3840 | 0.030 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 1999 | 420 | 0.030 |
Why?
|
Texas | 1 | 2014 | 402 | 0.030 |
Why?
|
Cattle | 1 | 1999 | 3845 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2014 | 414 | 0.030 |
Why?
|
Hospitalization | 1 | 2013 | 10652 | 0.030 |
Why?
|
Access to Information | 1 | 2016 | 319 | 0.030 |
Why?
|
Administration, Topical | 1 | 2014 | 697 | 0.030 |
Why?
|
Staphylococcus epidermidis | 1 | 2013 | 122 | 0.030 |
Why?
|
Kidney Failure, Chronic | 1 | 2005 | 2457 | 0.030 |
Why?
|
Aneurysm, False | 1 | 2014 | 254 | 0.020 |
Why?
|
Cost Savings | 1 | 2017 | 918 | 0.020 |
Why?
|
Workload | 1 | 2017 | 847 | 0.020 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15785 | 0.020 |
Why?
|
Vascular System Injuries | 1 | 2014 | 246 | 0.020 |
Why?
|
Aspirin | 1 | 2022 | 3131 | 0.020 |
Why?
|
Hospitals, University | 1 | 2013 | 567 | 0.020 |
Why?
|
Comprehension | 1 | 2016 | 619 | 0.020 |
Why?
|
Cohort Studies | 4 | 2012 | 41256 | 0.020 |
Why?
|
Hematoma | 1 | 2014 | 768 | 0.020 |
Why?
|
Equipment Design | 1 | 2017 | 3507 | 0.020 |
Why?
|
Software | 1 | 2003 | 4415 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 1999 | 1755 | 0.020 |
Why?
|
Clinical Competence | 2 | 2018 | 4775 | 0.020 |
Why?
|
Prospective Studies | 3 | 2021 | 54137 | 0.020 |
Why?
|
Educational Status | 1 | 2016 | 2513 | 0.020 |
Why?
|
Young Adult | 3 | 2024 | 58808 | 0.020 |
Why?
|
Obesity | 1 | 2009 | 12870 | 0.020 |
Why?
|
Arteries | 2 | 2002 | 1125 | 0.020 |
Why?
|
Proteins | 1 | 2001 | 6026 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 8945 | 0.020 |
Why?
|
Emergencies | 1 | 2013 | 1209 | 0.020 |
Why?
|
Survival Analysis | 2 | 2013 | 10112 | 0.020 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 694 | 0.020 |
Why?
|
Mesenteric Artery, Inferior | 1 | 2005 | 15 | 0.020 |
Why?
|
Stainless Steel | 1 | 2005 | 79 | 0.020 |
Why?
|
Curriculum | 1 | 2018 | 3717 | 0.020 |
Why?
|
Hospital Costs | 1 | 2010 | 960 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5484 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6741 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2850 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2017 | 3432 | 0.010 |
Why?
|
Body Weights and Measures | 1 | 2003 | 208 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 3242 | 0.010 |
Why?
|
Adolescent | 2 | 2024 | 87892 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 2006 | 1097 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2013 | 2768 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2013 | 4451 | 0.010 |
Why?
|
Contrast Media | 1 | 2015 | 5298 | 0.010 |
Why?
|
Communication | 1 | 2016 | 3846 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8530 | 0.010 |
Why?
|
Probability | 1 | 2006 | 2467 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8823 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 1999 | 18119 | 0.010 |
Why?
|
Epidemiologic Factors | 1 | 1999 | 36 | 0.010 |
Why?
|
Cote d'Ivoire | 1 | 1999 | 64 | 0.010 |
Why?
|
Myocardial Infarction | 2 | 2013 | 11424 | 0.010 |
Why?
|
Population Surveillance | 1 | 2009 | 2606 | 0.010 |
Why?
|
Animals, Wild | 1 | 1999 | 77 | 0.010 |
Why?
|
Disease Reservoirs | 1 | 1999 | 121 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2013 | 2239 | 0.010 |
Why?
|
Mortality | 1 | 2009 | 2886 | 0.010 |
Why?
|
Brain | 1 | 2004 | 26947 | 0.010 |
Why?
|
Remission Induction | 1 | 2003 | 2388 | 0.010 |
Why?
|
Cytoplasm | 1 | 2001 | 1514 | 0.010 |
Why?
|
Nutritional Status | 1 | 2005 | 1607 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2004 | 36284 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2002 | 18940 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 7378 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2001 | 3593 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2001 | 1312 | 0.010 |
Why?
|
Ecosystem | 1 | 1999 | 487 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2001 | 2105 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2001 | 1723 | 0.010 |
Why?
|
Aorta | 1 | 2001 | 2037 | 0.010 |
Why?
|
Spleen | 1 | 1999 | 2296 | 0.010 |
Why?
|
Animals | 2 | 1999 | 167768 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2001 | 11070 | 0.000 |
Why?
|
Liver | 1 | 1999 | 7502 | 0.000 |
Why?
|